Royalty Pharma (RPRX) Amortization - Intangibles (2019 - 2022)
Royalty Pharma (RPRX) posted Amortization - Intangibles of $5.7 million for Q1 2022, down 2.17% sequentially from $5.8 million in Q4 2021, and little changed YoY from $5.7 million in Q1 2021.
Royalty Pharma (RPRX) Amortization - Intangibles (2019 - 2022) Analysis & Trends
Royalty Pharma has reported Amortization - Intangibles for 4 years, with the latest figure at $5.7 million in Q1 2022.
- Quarterly Amortization - Intangibles changed 0.02% year-over-year to $5.7 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $5.7 million (down 75.34% YoY) and the FY2022 annual result came in at $5.7 million, down 75.34% from the prior year.
- Amortization - Intangibles retreated to $5.7 million in Q1 2022 per RPRX's latest filing, from $5.8 million in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $5.8 million in Q3 2019 and troughed at $5.7 million in Q1 2022.
- A 4-year average of $5.8 million and a median of $5.8 million in 2019 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2020 and 2021: Amortization - Intangibles changed 0.0% in 2020, then slipped 1.08% in 2021.
- Over 4 years, Amortization - Intangibles stood at $5.8 million in 2019, then changed by 0.0% to $5.8 million in 2020, then changed by 0.0% to $5.8 million in 2021, then declined by 2.17% to $5.7 million in 2022.
- According to Business Quant data, Amortization - Intangibles over the past three periods registered $5.7 million, $5.8 million, and $5.8 million for Q1 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 5.67 Mn |
| Dec 31, 2021 | 5.80 Mn |
| Sep 30, 2021 | 5.80 Mn |
| Jun 30, 2021 | 5.73 Mn |
| Mar 31, 2021 | 5.67 Mn |
| Dec 31, 2020 | 5.80 Mn |
| Sep 30, 2020 | 5.80 Mn |
| Jun 30, 2020 | 5.73 Mn |
| Mar 31, 2020 | 5.73 Mn |
| Dec 31, 2019 | 5.80 Mn |
| Sep 30, 2019 | 5.80 Mn |
| Jun 30, 2019 | 5.73 Mn |